Browse By: Country ι Category ι Tag
Home  »  Generic Drugs

Generic Drugs Market Research Reports

More

Generic Pharmaceuticals (Global) - Industry Report
Plimsoll Publishing’s Generic Pharmaceuticals (Global) Analysis provides a detailed overview of the Generic Pharmaceuticals (Global) market and delivers a comprehensive individual analysis on the top 200 companies, including NOVARTIS AG, SIGMA PHARMACEUTICALS LIMITED and RICHTER GEDEON VEGYESZETI GYAR RT.  This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Generic Pharmaceuticals (Global) analysis is ideal for anyone wanting to: See the market leaders Identify companies heading for failure Seek out the most attractive acquisition Analyse industry trends Benchmark their own financial performance Using Plimsoll’s exclusive methodology, a quick glance of this Ge
Published Date: Jan 2014
Published By: Plimsoll Publishing Ltd.

Price: $1425
Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues
GBI Researchs report, Drug Recalls and Warning Letters - Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-compliance Issues, provides in-depth analysis of Warning Letters, drug recalls issued or reported with the US Food and Drug Administration (FDA) and its constituent agencies. The report analyzes warning letters from the issuing agencies and reason for these warning letters. The report contains year by year detailed analysis about warning letters issued for various reasons by regulatory authorities. The report is built on data and information sourced from the FDA database of warning letters and drug recalls and in-house analysis by GBI Researchs team of industry experts. GBI Research indicates that the warning letters and drug recalls have significantly increa
Published Date: Nov 2011
Published By: GBI Research

Price: $3500
Oligodendroglioma Global Clinical Trials Review, Q4, 2010
GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, Q4, 2010"" provides data on the Oligodendroglioma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Oligodendroglioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Oligodendroglioma).  This report is built using data and information sourced from proprietary databases, primary and se
Published Date: Dec 2010
Published By: GlobalData

Price: $1000

Back To Top